Navigation

Publications

Publications since 01.01.2017 (project start):

  1. Reshetnikov, V.; Daum, S.; Janko, C.; Karawacka, W.; Tietze, R.; Alexiou, C.; Paryzhak, S.; Dumych, T.; Bilyy, R.; Tripal, P.; Schmid, B.; Palmisano, R.; Mokhir, A.* ROS-responsive N-alkylaminoferrocenes for cancer cell specific targeting of mitochondriaAngew. Chem., 2018, accepted. Link: https://doi.org/10.1002/anie.201805955
  2. Reshetnikov, V.; Hahn, J.; Maueröder, C.; Czegley, C.; Munoz, L. E.; Herrmann, M.; Hoffmann, M. H.;* Mokhir, A.* Chemical tools for targeted amplification of reactive oxygen species in neutrophils. Frontiers in Immunology, 2018, accepted.
  3. Reshetnikov, V.; Arkhypov, A.; Julakanti, P. R., Mokhir, A.* A cancer specific oxaliplatin-releasing Pt(IV)-prodrugDalton Trans.2018, 47, 6679-6682.
  4. Daum, S.; Babiy, S.; Konovalova, H.; Hofer, W.; Shtemenko, A.; Shtemenko, N.; Janko, C.; Alexiou, C.; Mokhir, A.* Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution. J. Inorg. Biochem., 2018, 178, 9-17.
  5. T. Fröhlich, C. Reiter, M. M. Ibrahim, J. Beutel, C. Hutterer, I. Zeitträger, H. Bahsi, M. Leidenberger, O. Friedrich, B. Kappes, T. Efferth, M. Marschall, S. B. Tsogoeva. Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells. ACS Omega, 2017, 2, 2422-2431.
  6. F. E. Held, A. A. Guryev, T. Fröhlich, F. Hampel, A. Kahnt, C. Hutterer, M. Steingruber, H. Bahsi, C. von Bojnicic-Kninski, D. S. Mattes, T. C. Foertsch, A. Nesterov-Mueller, M. Marschall, S. B. Tsogoeva, Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions. Nature Communications, 2017, 15071.
  7. C. M. Bock, G. Parameshwarappa, S. Bönisch, W. Bauer, C. Hutterer, M. Leidenberger, O. Friedrich, M. Marschall, B. Kappes, A. Görling, S. B. Tsogoeva. Deeper Insight into the Six-Step Domino Reaction of Aldehydes with Malononitrile and Evaluation of Antiviral and Antimalarial Activities of the Obtained Bicyclic Products. ChemistryOpen, 2017, DOI: 10.1002/open.201700005.